View ValuationSelectQuote 향후 성장Future 기준 점검 0/6SelectQuote 의 수익은 연간 183.4% 감소할 것으로 예상되는 반면, 연간 수익은 5% 로 증가할 것으로 예상됩니다. EPS는 연간 182.9% 만큼 쇠퇴할 것으로 예상됩니다.핵심 정보-183.4%이익 성장률-182.89%EPS 성장률Insurance 이익 성장2.1%매출 성장률5.0%향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트14 May 2026최근 향후 성장 업데이트공시 • May 07SelectQuote, Inc. Reaffirms Earnings Guidance for the Fiscal Year 2026SelectQuote, Inc. reaffirmed earnings guidance for the Fiscal Year 2026. For the year, the company's revenue is expected to be in a range of $1.61 billion to $1.71 billion.공시 • Feb 05SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2026SelectQuote, Inc. provided earnings guidance for the fiscal year 2026. For the year, the company revenue expected in a range of $1.61 billion to $1.71 billion.공시 • Aug 21+ 1 more updateSelectQuote, Inc. Provides Earnings Guidance for the Full Year 2026SelectQuote, Inc. provided earnings guidance for the full year 2026. for the year, the company's revenue expected in a range of $1.650 billion to $1.750 billion.공시 • May 12SelectQuote, Inc. Provides Earnings Guidance for the Year Ending June 30, 2025SelectQuote, Inc. provided earnings guidance for the year ending June 30, 2025. For the year, the company expects revenue to be in the range of $1.500 billion to $1.575 billion and net income to be in the range of negative $1,000,000 to positive $28,000,000.공시 • Feb 11SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2025SelectQuote, Inc. provided earnings guidance for the fiscal year ending June 30, 2025. For the period, the company's Revenue is expected in a range of $1.500 billion to $1.575 billion. Net loss expected in a range of $24 million to Net income of $11 million.공시 • Nov 05SelectQuote, Inc. Provides Unaudited Earnings Guidance for the Fiscal Year Ending June 30, 2025SelectQuote, Inc. provided unaudited earnings guidance for the fiscal year ending June 30, 2025. For the year, the company expects revenue to be in a range of $1.425 billion to $1.525 billion. Net income to be in a range of negative 59 million to $3 million.모든 업데이트 보기Recent updates공시 • May 07SelectQuote, Inc. Reaffirms Earnings Guidance for the Fiscal Year 2026SelectQuote, Inc. reaffirmed earnings guidance for the Fiscal Year 2026. For the year, the company's revenue is expected to be in a range of $1.61 billion to $1.71 billion.공시 • Apr 21SelectQuote, Inc. to Report Q3, 2026 Results on May 05, 2026SelectQuote, Inc. announced that they will report Q3, 2026 results Pre-Market on May 05, 2026공시 • Mar 26SelectQuote, Inc. Receives Notice of Non-Compliance with NYSE Listing StandardOn March 19, 2026, SelectQuote, Inc. (the Company) received a notice (the Notice) from the New York Stock Exchange (the NYSE) indicating that the Company is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period. The Company will notify the NYSE of its intent to cure the stock price deficiency and return to compliance with the continued listing standard. The Company can regain compliance at any time within the six-month cure period following receipt of the Notice if, on the last trading day of any calendar month during the cure period, the Company's common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. The Company intends to closely monitor its stock price during the cure period and will, if necessary, consider available alternatives to cure the stock price deficiency. If the Company determines that curing the deficiency will require taking action that must be approved by the Company's stockholders, the price condition will be deemed cured if the price of the Company's common stock promptly exceeds $1.00 per share following such action and remains above that level for at least the following 30 trading days. The Company's common stock will continue to be listed and traded on the NYSE during the cure period, subject to the Company's compliance with other NYSE continued listing standards.공시 • Mar 17SelectQuote, Inc. Announces SelectQuote Local Franchise ModelSelectQuote, Inc. announced an initiative to expand its reach and complement its existing, telephonic insurance distribution model. SelectQuote Local will leverage the Company’s marketing, technology, customer service, and carrier relationships to offer consumers its senior health and life insurance products through a franchise model offering local sales and support. SelectQuote Local provides consumers the opportunity to meet with local representatives while still offering the Company’s same affordable and simple way to quickly and easily find the type of insurance to meet their unique needs. Franchise owners will have an opportunity to purchase rights to operate their SelectQuote Local franchise in a particular geographic region, providing a business opportunity for them and a new growth opportunity for the Company.공시 • Feb 05SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2026SelectQuote, Inc. provided earnings guidance for the fiscal year 2026. For the year, the company revenue expected in a range of $1.61 billion to $1.71 billion.공시 • Jan 22SelectQuote, Inc. to Report Q2, 2026 Results on Feb 05, 2026SelectQuote, Inc. announced that they will report Q2, 2026 results Pre-Market on Feb 05, 2026공시 • Oct 23SelectQuote, Inc. to Report Q1, 2026 Results on Nov 06, 2025SelectQuote, Inc. announced that they will report Q1, 2026 results Pre-Market on Nov 06, 2025공시 • Oct 03SelectQuote, Inc., Annual General Meeting, Nov 11, 2025SelectQuote, Inc., Annual General Meeting, Nov 11, 2025.공시 • Aug 21+ 1 more updateSelectQuote, Inc. Provides Earnings Guidance for the Full Year 2026SelectQuote, Inc. provided earnings guidance for the full year 2026. for the year, the company's revenue expected in a range of $1.650 billion to $1.750 billion.공시 • Aug 07SelectQuote, Inc. to Report Q4, 2025 Results on Aug 21, 2025SelectQuote, Inc. announced that they will report Q4, 2025 results Pre-Market on Aug 21, 2025공시 • Jul 17SelectQuote, Inc. Unveils New Program Designed to Elevate Health Plan Performance by Improving Medication Adherence for Polychronic Medicare BeneficiariesSelectQuote, Inc. announced the expanded launch of their innovative concierge-like service designed to specifically improve medication adherence for Medicare beneficiaries managing multiple chronic conditions and complex medication regimens. SelectQuote's SelectRx pharmacy recently trialed a new approach with a regional health plan that demonstrated over 90% adherence, strengthening HEDIS Star ratings across the triple-weighted cholesterol, diabetes and hypertension measures. The Company plans to expand to additional payers this calendar year and will roll out across SelectRx's pharmacy platform in 2026. This program further demonstrates SelectQuote's deep commitment to driving better health outcomes and greater value for both patients and payer partners. This high-touch solution is purpose-built to address the critical challenge of medication non-adherence, which often leads to preventable hospitalizations, adverse drug interactions, and escalating healthcare costs for the Medicare system. SelectQuote aims to help patients overcome adherence barriers through escalations to its clinical pharmacist team, who can provide specialized intervention. The Company also plans to launch a complementary program for lower risk members to support their continued medication adherence.공시 • Jul 03SelectQuote, Inc. Announces Demise of Tom Grant, Vice Chairman of the Board of Directors, on July 1, 2025SelectQuote, Inc. announced that William Thomas (Tom) Grant II, Vice Chairman and former President of company, passed away on July 1, 2025, following a battle with cancer. Tom was instrumental in formulating and executing company's strategy over the past fifteen years as the business evolved from a term life insurance brokerage into a diversified insurance and rapidly-growing healthcare services business. His strategic insights and dedication were pivotal to the company’s success. Tom also personally touched the lives of thousands of company associates and their families with his wit, warmth, and ever-present smile.공시 • May 12SelectQuote, Inc. Provides Earnings Guidance for the Year Ending June 30, 2025SelectQuote, Inc. provided earnings guidance for the year ending June 30, 2025. For the year, the company expects revenue to be in the range of $1.500 billion to $1.575 billion and net income to be in the range of negative $1,000,000 to positive $28,000,000.공시 • May 05SelectQuote, Inc. to Report Q3, 2025 Results on May 12, 2025SelectQuote, Inc. announced that they will report Q3, 2025 results on May 12, 2025공시 • Mar 01SelectQuote, Inc. announced that it has received $350 million in funding from Bain Capital, LP, Morgan Stanley, Investment Arm, Newlight Partners LPOn February 28, 2025. SelectQuote, Inc. has closed the transaction. it has issued 350,000 shares of Senior Non-Convertible Preferred Stock at a price of $1,000 per share for proceeds of $350,000,000 and 30,833,333 warrants to purchase shares of the Company’s common stock.공시 • Feb 12SelectQuote, Inc. announced that it expects to receive $350 million in funding from Bain Capital, LP, Morgan Stanley, Investment Arm, Newlight Partners LPSelectQuote, Inc. announced that it has entered into agreement with Bain Capital, Morgan Stanley Private Credit, and Newlight Partners for gross proceeds of $350 million on February 10, 2025. Additionally, SelectQuote is appointing Chris Wolfe of Bain Capital and Srdjan Vukovic of Newlight Partners to the Board of Directors, each bringing over 20 years of investing and healthcare sector experience to the Company. SelectQuote anticipates Mr. Wolfe and Mr. Vukovic will join the Board upon the closing of the transaction, expected to be on February 28, 2025.공시 • Feb 11SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2025SelectQuote, Inc. provided earnings guidance for the fiscal year ending June 30, 2025. For the period, the company's Revenue is expected in a range of $1.500 billion to $1.575 billion. Net loss expected in a range of $24 million to Net income of $11 million.공시 • Feb 04SelectQuote, Inc. to Report Q2, 2025 Results on Feb 10, 2025SelectQuote, Inc. announced that they will report Q2, 2025 results After-Market on Feb 10, 2025공시 • Nov 05SelectQuote, Inc. Provides Unaudited Earnings Guidance for the Fiscal Year Ending June 30, 2025SelectQuote, Inc. provided unaudited earnings guidance for the fiscal year ending June 30, 2025. For the year, the company expects revenue to be in a range of $1.425 billion to $1.525 billion. Net income to be in a range of negative 59 million to $3 million.Reported Earnings • Nov 05First quarter 2025 earnings released: US$0.26 loss per share (vs US$0.18 loss in 1Q 2024)First quarter 2025 results: US$0.26 loss per share (further deteriorated from US$0.18 loss in 1Q 2024). Revenue: US$292.3m (up 26% from 1Q 2024). Net loss: US$44.5m (loss widened 44% from 1Q 2024). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.9% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.New Risk • Oct 29New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$34m Forecast net loss in 2 years: US$1.4m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$1.4m net loss in 2 years). Shareholders have been diluted in the past year (2.2% increase in shares outstanding).공시 • Oct 23SelectQuote, Inc. to Report Q1, 2025 Results on Nov 04, 2024SelectQuote, Inc. announced that they will report Q1, 2025 results Pre-Market on Nov 04, 2024공시 • Oct 03SelectQuote, Inc., Annual General Meeting, Nov 12, 2024SelectQuote, Inc., Annual General Meeting, Nov 12, 2024.New Risk • Sep 15New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Shareholders have been diluted in the past year (2.2% increase in shares outstanding).Reported Earnings • Sep 14Full year 2024 earnings released: US$0.20 loss per share (vs US$0.35 loss in FY 2023)Full year 2024 results: US$0.20 loss per share (improved from US$0.35 loss in FY 2023). Revenue: US$1.32b (up 32% from FY 2023). Net loss: US$34.1m (loss narrowed 42% from FY 2023). Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 43% per year, which means it is performing significantly worse than earnings.공시 • Sep 13SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2025SelectQuote, Inc. provided earnings guidance for the fiscal year 2025. For the year, the company expects Revenue in a range of $1.4 billion to $1.5 billion. Net loss expected in a range of $42 million to $6 million.공시 • Sep 11SelectQuote, Inc. to Report Q4, 2024 Results on Sep 13, 2024SelectQuote, Inc. announced that they will report Q4, 2024 results Pre-Market on Sep 13, 2024공시 • May 10SelectQuote, Inc. Raises Earnings Guidance for the Fiscal Year 2024SelectQuote, Inc. raised earnings guidance for the fiscal year 2024. For the year, the company's revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion. Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million.Reported Earnings • May 09Third quarter 2024 earnings released: EPS: US$0.051 (vs US$0.056 in 3Q 2023)Third quarter 2024 results: EPS: US$0.051 (down from US$0.056 in 3Q 2023). Revenue: US$376.4m (up 26% from 3Q 2023). Net income: US$8.55m (down 7.7% from 3Q 2023). Profit margin: 2.3% (down from 3.1% in 3Q 2023). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.공시 • May 03SelectQuote, Inc. to Report Q3, 2024 Results on May 09, 2024SelectQuote, Inc. announced that they will report Q3, 2024 results Pre-Market on May 09, 2024New Risk • Feb 29New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$50m Forecast net loss in 2 years: US$1.8m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$3.6m free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$1.8m net loss in 2 years). Share price has been volatile over the past 3 months (9.2% average weekly change).Reported Earnings • Feb 08Second quarter 2024 earnings released: EPS: US$0.12 (vs US$0.14 in 2Q 2023)Second quarter 2024 results: EPS: US$0.12 (down from US$0.14 in 2Q 2023). Revenue: US$405.4m (up 27% from 2Q 2023). Net income: US$19.4m (down 14% from 2Q 2023). Profit margin: 4.8% (down from 7.1% in 2Q 2023). Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Insurance industry in Germany.공시 • Feb 08SelectQuote, Inc. Revises Earnings Guidance for the Fiscal Year 2024SelectQuote, Inc. revised earnings guidance for the Fiscal Year 2024. For the year, company expects Revenue in a range of $1.23 billion to $1.3 billion vs prior range of $1.05 billion to $1.2 billion and Net loss expected in a range of $45 million to $22 million vs prior range of $50 million to $22 million.공시 • Jan 24SelectQuote, Inc. to Report Q2, 2024 Results on Feb 07, 2024SelectQuote, Inc. announced that they will report Q2, 2024 results Pre-Market on Feb 07, 2024공시 • Nov 03SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2024SelectQuote, Inc. provided earnings guidance for the fiscal year 2024. For the year, the company expects revenue of $232.7 million and net loss of $31.1 million.Reported Earnings • Nov 03First quarter 2024 earnings released: US$0.18 loss per share (vs US$0.26 loss in 1Q 2023)First quarter 2024 results: US$0.18 loss per share (improved from US$0.26 loss in 1Q 2023). Revenue: US$232.7m (up 43% from 1Q 2023). Net loss: US$31.1m (loss narrowed 27% from 1Q 2023). Revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 6 percentage points per year, which is a significant difference in performance.공시 • Oct 26SelectQuote, Inc. to Report Q1, 2024 Results on Nov 02, 2023SelectQuote, Inc. announced that they will report Q1, 2024 results After-Market on Nov 02, 2023공시 • Oct 05SelectQuote, Inc., Annual General Meeting, Nov 14, 2023SelectQuote, Inc., Annual General Meeting, Nov 14, 2023, at 09:00 Central Standard Time. Agenda: To consider the election of two Class I directors named in proxy statement to serve until the 2026 annual meeting of stockholders or until their successors are duly elected and qualified; to consider a proposal to ratify the appointment of Deloitte & Touche LLP as company's independent registered public accounting firm for company's fiscal year ending June 30, 2024; to consider a proposal to approve, by non-binding advisory vote, the compensation of company's named executive officers; and to consider any other business as may properly come before the Annual Meeting.New Risk • Sep 24New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$59m Forecast net loss in 2 years: US$21m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (US$21m net loss in 2 years).Recent Insider Transactions • Sep 19President of SelectQuote Senior recently bought €106k worth of stockOn the 18th of September, Joshua Matthews bought around 98k shares on-market at roughly €1.09 per share. This transaction amounted to 32% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €1.2m more in shares than they have sold in the last 12 months.공시 • Sep 14+ 1 more updateSelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2024SelectQuote, Inc. provided earnings guidance for the fiscal year 2024. For the period, Revenue expected in a range of $1.05 billion to $1.2 billion and Net loss expected in a range of $50 million to $22 million.New Risk • Sep 14New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$59m Forecast net loss in 2 years: US$1.4m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (US$1.4m net loss in 2 years).Reported Earnings • Sep 14Full year 2023 earnings released: US$0.35 loss per share (vs US$1.81 loss in FY 2022)Full year 2023 results: US$0.35 loss per share (improved from US$1.81 loss in FY 2022). Revenue: US$1.00b (up 31% from FY 2022). Net loss: US$58.5m (loss narrowed 80% from FY 2022). Revenue is forecast to grow 8.8% p.a. on average during the next 2 years, compared to a 2.6% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 9 percentage points per year, which is a significant difference in performance.공시 • Aug 24SelectQuote, Inc. to Report Q4, 2023 Results on Sep 13, 2023SelectQuote, Inc. announced that they will report Q4, 2023 results Pre-Market on Sep 13, 2023Recent Insider Transactions • May 18Vice Chairman recently bought €501k worth of stockOn the 16th of May, William Grant bought around 425k shares on-market at roughly €1.18 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was William's only on-market trade for the last 12 months.공시 • May 13SelectQuote, Inc. Updates Consolidated Earnings Guidance for the Fiscal Year 2023SelectQuote, Inc. updated consolidated earnings guidance for the fiscal year 2023. For the period, the company expected revenue in a range of $950 million to $970 million. Net loss now expected in a range of $73 million to $55 million.공시 • May 12SelectQuote, Inc. Provides Consolidated Earnings Guidance for the Third Quarter and Full Year of Fiscal 2023SelectQuote, Inc. provided consolidated earnings guidance for the third quarter and full year of fiscal 2023. For the quarter, the company expects revenue of $299.4 million. Net income of $9.3 million.For the full year, the company expects revenue now expected in a range of $950 million to $970 million. Net loss now expected in a range of $68 million to $48 million.Reported Earnings • May 11Third quarter 2023 earnings released: EPS: US$0.056 (vs US$0.039 loss in 3Q 2022)Third quarter 2023 results: EPS: US$0.056 (up from US$0.039 loss in 3Q 2022). Revenue: US$299.4m (up 8.8% from 3Q 2022). Net income: US$9.26m (up US$15.7m from 3Q 2022). Profit margin: 3.1% (up from net loss in 3Q 2022). Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Insurance industry in Germany.공시 • Feb 08SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2023SelectQuote, Inc. provides earnings guidance for the fiscal year 2023. The company now expects revenue in a range of $910 million to $960 million. Net loss now expected in a range of $94 million to $78 million.Reported Earnings • Feb 08Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.84 loss in 2Q 2022)Second quarter 2023 results: EPS: US$0.14 (up from US$0.84 loss in 2Q 2022). Revenue: US$319.2m (up 64% from 2Q 2022). Net income: US$22.5m (up US$159.5m from 2Q 2022). Profit margin: 7.1% (up from net loss in 2Q 2022). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Insurance industry in Germany.공시 • Jan 20SelectQuote, Inc. to Report Q2, 2023 Results on Feb 07, 2023SelectQuote, Inc. announced that they will report Q2, 2023 results Pre-Market on Feb 07, 2023공시 • Jan 06+ 1 more updateSelectQuote, Inc. Provides Earnings Guidance for the Second Quarter 2023SelectQuote, Inc. provides earnings guidance for the second quarter 2023. Revenue for the second quarter of fiscal year 2023 expected in a range of $300 million to $320 million. Net income for the second quarter of fiscal year 2023 expected in a range of $11 million to $23 million.Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 3 highly experienced directors. Vice Chairman Tom Grant is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Nov 04First quarter 2023 earnings released: US$0.26 loss per share (vs US$0.29 loss in 1Q 2022)First quarter 2023 results: US$0.26 loss per share (improved from US$0.29 loss in 1Q 2022). Revenue: US$162.5m (up 3.1% from 1Q 2022). Net loss: US$42.5m (loss narrowed 9.9% from 1Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Insurance industry in Germany.공시 • Nov 04Selectquote, Inc. Reaffirms Earnings Guidance for the Fiscal Year 2023SelectQuote, Inc. reaffirmed earnings guidance for the Fiscal Year 2023. For the year, the company's Revenue expected in a range of $850 million to $950 million and net loss expected in a range of $113 million to $89 million.공시 • Oct 27SelectQuote Announces Receipt of Continued Listing Standard Notice from NYSESelectQuote, Inc. (the “Company”) announced that it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) indicating that the Company is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period. The Company will notify the NYSE of its intent to cure the stock price deficiency and return to compliance with the continued listing standard. The Company can regain compliance at any time within the six-month cure period following receipt of the Notice if, on the last trading day of any calendar month during the cure period, the Company’s common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. The Company intends to closely monitor its stock price during the cure period and will, if necessary, consider available alternatives to cure the stock price non-compliance.공시 • Oct 15SelectQuote, Inc. to Report Q1, 2023 Results on Nov 03, 2022SelectQuote, Inc. announced that they will report Q1, 2023 results Pre-Market on Nov 03, 2022공시 • Oct 07SelectQuote, Inc., Annual General Meeting, Nov 15, 2022SelectQuote, Inc., Annual General Meeting, Nov 15, 2022, at 09:00 Central Standard Time. Agenda: To consider the election of three Class III directors named in this proxy statement to serve until the 2025 annual meeting of stockholders or until their successors are duly elected and qualified; to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending June 30, 2023; to approve, by non-binding advisory vote, the Company’s executive compensation program; and to transact other business.Reported Earnings • Aug 30Full year 2022 earnings released: US$1.81 loss per share (vs US$0.81 profit in FY 2021)Full year 2022 results: US$1.81 loss per share (down from US$0.81 profit in FY 2021). Revenue: US$764.0m (down 19% from FY 2021). Net loss: US$297.5m (down 327% from profit in FY 2021). Over the next year, revenue is forecast to grow 19%, compared to a 27% growth forecast for the Insurance industry in Germany.공시 • Aug 30Selectquote, Inc. Reports Unaudited Consolidated Impairment for the Three Months Ended June 30, 2022SelectQuote, Inc. reported unaudited consolidated impairment for the three months ended June 30, 2022. For the quarter, the company reported Goodwill impairment of $44,596,000. Impairment of long-lived assets is $3,147,000.공시 • Aug 26SelectQuote, Inc. Appoints Alan Muney as Chief Medical OfficerSelectQuote, Inc. has hired Alan Muney, MD, as part-time Chief Medical Officer. Dr. Muney will focus on healthcare strategy solutions for SelectQuote healthcare services, which encompasses Population Health and SelectRx, bringing extensive experience operating clinical strategy within a national Medicare Advantage health plan and large provider groups. Dr. Muney will provide strategic guidance on program development and execution for health plan initiatives focusing on member engagement, clinical quality, and care delivery. He will also drive initiatives that support healthcare services members in accessing high-value medical and clinical services to achieve improved health outcomes. Dr. Muney is a physician and executive leader with more than 35 years of experience leading healthcare payor and provider organizations. Most recently, he served as Cigna's Chief Medical Officer and EVP of Total Health and Network, overseeing clinical strategy, coverage policy, quality measurement and improvement, and total health physician and clinical operations. Before Cigna, Dr. Muney was an Executive Director in the Private Equity Group at Blackstone and the CEO of Equity Healthcare, which he founded to manage the healthcare costs of Blackstone's portfolio companies. Alan was also EVP, Chief Medical Officer of Oxford Health Plans, and Chief Medical Officer of UnitedHealthcare of the Northeast region from 1998-2007.공시 • Jul 28SelectQuote, Inc. to Report Q4, 2022 Results on Aug 18, 2022SelectQuote, Inc. announced that they will report Q4, 2022 results Pre-Market on Aug 18, 2022공시 • Jun 26SelectQuote, Inc.(NYSE:SLQT) dropped from Russell 2000 Growth IndexSelectQuote, Inc.(NYSE:SLQT) dropped from Russell 2000 Growth Index공시 • May 20Selectquote, Inc. Announces CFO ChangesSelectQuote, Inc. announced the departure of Chief Financial Officer Raff Sadun after 5 years at SelectQuote to pursue a new opportunity outside of the industry. The Board of Directors approved the appointment of Ryan Clement, SVP of Financial Planning & Analysis, as interim CFO effective upon Sadun’s departure at the end of the month. Prior to joining SelectQuote, Clement served as the CFO of a software technology company and has over a decade of experience in senior-level finance and operations roles. Clement will continue to lead SelectQuote’s Financial Planning & Analysis organization while acting as interim CFO. The company’s financial reporting and accounting functions will be led by Stephanie Fisher, SelectQuote’s Chief Accounting Officer, who will assume the role of principal accounting officer effective upon Sadun’s departure. The company has initiated a national search for a permanent Chief Financial Officer.Reported Earnings • May 09Third quarter 2022 earnings released: US$0.039 loss per share (vs US$0.22 profit in 3Q 2021)Third quarter 2022 results: US$0.039 loss per share (down from US$0.22 profit in 3Q 2021). Revenue: US$275.1m (up 3.7% from 3Q 2021). Net loss: US$6.45m (down 118% from profit in 3Q 2021). Over the next year, revenue is forecast to grow 9.7%, compared to a 19% growth forecast for the industry in Germany.Board Change • May 09High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 3 highly experienced directors. Vice Chairman Tom Grant is the most experienced director on the board, commencing their role in 2010. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • May 06Selectquote, Inc. Provides Earnings Guidance for the Year Ending June 30, 2022SelectQuote, Inc. provided earnings guidance for the year ending June 30, 2022. For the period, the company's Revenue expected in a range of $810 million to $850 million. Net Loss expected in a range of $255 million to $236 million.공시 • Apr 26SelectQuote, Inc. to Report Q3, 2022 Results on May 05, 2022SelectQuote, Inc. announced that they will report Q3, 2022 results Pre-Market on May 05, 2022공시 • Mar 03Selectquote, Inc. Introduces Healthcare Advisory BoardSelectQuote, Inc. announced the formation of a Healthcare Advisory Board to help the company strengthen the mission and clinical strategy of Population Health. This group of world-class experts will advise Population Health on ways to empower, engage and educate consumers on healthcare solutions and benefits, equipping them to lead healthier lives through improved health outcomes while reducing costs for patients and the healthcare system. This group of world-renowned leaders brings comprehensive healthcare expertise from the pharmaceutical, health IT, payer, provider, and regulatory market segments and will provide important insight and expertise to help shape continuing innovation and growth at Population Health. The Advisory Board will be led by SelectQuote Board members Kavita Patel, MD and Earl “Trace” Devanny. Advisory Board members include: Basit Chaudhry, MD is an internal medicine physician and medical technologist who founded Tuple Health in 2013. His expertise spans healthcare payment, clinical service redesign, and the use of data analytics to improve clinical and financial performance in healthcare. Alan Muney, MD is currently an external advisor to Bain & Company, and a Senior Advisor for Pritzker Private Capital, NEA and Arsenal Capital Partners. From 2010 to 2018, he was the Executive Vice President and Chief Medical Officer for Cigna, leading the company’s health management and network contracting activities. Joe Grogan is a former Assistant to the President, Director of the Domestic Policy Council and Associate Director, Health Programs for the Office of Management and Budget. He is currently a Fellow with the USC Schaeffer Center. He has served at senior management roles at Amgen, Inc., and Gilead Sciences, Inc., and he has an extensive background working with the FDA on regulatory, legislative and policy initiatives. Rebekah Gee, MD is the President and Founder of Nest Health and CEO of Healthcare Services for LSU Health. She formerly served as Secretary of the Louisiana Department of Health, the state’s large agency. She is a policy expert and is widely published in health services research, and has served in numerous additional state and national policy roles. Dr. Patel is currently a Fellow with the Brookings Institute and served in the Obama Administration as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement. She is also an advisor to the Bipartisan Policy Center and a member of Health and Human Services Physician Focused Payment Model Technical Advisory Committee. Devanny is the former CEO of Tract Manager, a provider of healthcare strategic sourcing and compliance application suites. From 2014 to 2016, he served as President of Nuance Communications’ healthcare business. He has also led healthcare company Trizetto Corporation and health information technology company Cerner Corporation.공시 • Feb 10SelectQuote, Inc. announced delayed 10-Q filingOn 02/09/2022, SelectQuote, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Buying Opportunity • Feb 09Now 43% undervalued after recent price dropOver the last 90 days, the stock is down 67%. The fair value is estimated to be US$5.65, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.9% over the last year. The company became loss making over the last year.Reported Earnings • Feb 08Second quarter 2022 earnings: EPS in line with expectations, revenues disappointSecond quarter 2022 results: US$0.84 loss per share (down from US$0.56 profit in 2Q 2021). Revenue: US$195.0m (down 46% from 2Q 2021). Net loss: US$137.0m (down 252% from profit in 2Q 2021). Revenue missed analyst estimates by 57%. Over the next year, revenue is forecast to grow 83%, compared to a 15% growth forecast for the industry in Germany.공시 • Feb 08SelectQuote, Inc. Provides Earnings Guidance for the Full Year of Fiscal 2022SelectQuote, Inc. provided earnings guidance for the full year of fiscal 2022. For the full year, the company expects revenue in a range of $810 million to $850 million and net Loss in a range of $255 million to $236 million.Reported Earnings • Nov 05First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.005 profit in 1Q 2021)The company reported a soft first quarter result with weaker earnings and weaker control over costs, although revenues improved. First quarter 2022 results: Revenue: US$159.9m (up 29% from 1Q 2021). Net loss: US$45.4m (down US$46.2m from profit in 1Q 2021).Recent Insider Transactions • Sep 12Vice Chairman recently bought €1.5m worth of stockOn the 10th of September, William Grant bought around 145k shares on-market at roughly €10.50 per share. In the last 3 months, they made an even bigger purchase worth €1.7m. This was William's only on-market trade for the last 12 months.Valuation Update With 7 Day Price Move • Sep 03Investor sentiment improved over the past weekAfter last week's 38% share price gain to €9.37, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 10x in the Insurance industry in Germany. Total loss to shareholders of 44% over the past year.Recent Insider Transactions • Sep 01Chief Operating Officer recently bought €1.7m worth of stockOn the 30th of August, William Grant bought around 230k shares on-market at roughly €7.50 per share. This was the largest purchase by an insider in the last 3 months. This was William's only on-market trade for the last 12 months.공시 • Aug 28SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2022SelectQuote, Inc. provided earnings guidance for the fiscal year 2022. For the period, The company expects revenue to be in the range of $1.25 billion and $1.4 billion, which would represent revenue growth of 33% and 49% year-over-year.Reported Earnings • Aug 26Full year 2021 earnings released: EPS US$0.81 (vs US$0.16 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: US$937.8m (up 76% from FY 2020). Net income: US$131.0m (up US$147.1m from FY 2020). Profit margin: 14% (up from net loss in FY 2020). The move to profitability was driven by higher revenue.공시 • Aug 19Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against SelectQuote, IncGlancy Prongay & Murray LLP (‘GPM’) announced that it has filed a class action lawsuit in the United States District Court for the Southern District of New York captioned Hartel v.SelectQuote, Inc., et al., (Case No. 21-cv-06903) on behalf of persons and entities that purchased or otherwise acquired SelectQuote, Inc. (‘SelectQuote’ or ‘the Company’) securities between February 8, 2021 and May 11, 2021, inclusive (the ‘Class Period’). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ‘Exchange Act’). Investors are hereby notified that they have 60 days from this notice to move the Court to serve as lead plaintiff in this action. On May 11, 2021, SelectQuote held a conference call in connection with its third quarter 2021 financial results during which it disclosed that its fourth quarter results would be impacted by a ‘negative cohort and tail adjustment’ due to ‘lower second-term persistency for the 2019 cohort.’ On this news, the Company’s share price fell $5.50, or 20%, to close at $21.90 per share on May 12, 2021, on unusually heavy trading volume. The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made material misrepresentations concerning the following: (1) that SelectQuote’s 2019 cohort was underperforming; (2) that, as a result, the Company’s financial results would be adversely impacted; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Valuation Update With 7 Day Price Move • Aug 14Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to US$11.74, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Insurance industry in Germany. Total loss to shareholders of 32% over the past year.공시 • Jun 28+ 2 more updatesSelectQuote, Inc.(NYSE:SLQT) dropped from Russell 3000 Value IndexSelectQuote, Inc.(NYSE:SLQT) dropped from Russell 3000 Value IndexReported Earnings • May 13Third quarter 2021 earnings released: EPS US$0.22 (vs US$0.23 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: US$266.9m (up 80% from 3Q 2020). Net income: US$36.5m (up 76% from 3Q 2020). Profit margin: 14% (in line with 3Q 2020).공시 • May 12SelectQuote, Inc. Provides Consolidated Earnings Guidance for the Full Year Ending June 30, 2021SelectQuote, Inc. provided consolidated earnings guidance for the full year ending June 30, 2021. For the year, the company expects revenue to be in the range of $920 million to $940 million and net income to be in the range of $130 million to $138 million.공시 • May 04SelectQuote, Inc. (NYSE:SLQT) acquired Express Med Pharmaceuticals, Inc.SelectQuote, Inc. (NYSE:SLQT) acquired Express Med Pharmaceuticals, Inc. on May 3, 2021. MyMedPak will be branded as SelectRx. SelectQuote, Inc. (NYSE:SLQT) completed the acquisition of Express Med Pharmaceuticals, Inc. on May 3, 2021.Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to US$22.20, the stock is trading at a trailing P/E ratio of 27.3x, down from the previous P/E ratio of 32.5x. This compares to an average P/E of 13x in the Insurance industry in Germany.공시 • Mar 05SelectQuote, Inc. has completed a Follow-on Equity Offering in the amount of $291.5 million.SelectQuote, Inc. has completed a Follow-on Equity Offering in the amount of $291.5 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 10,600,000 Price\Range: $27.5Is New 90 Day High Low • Mar 01New 90-day high: €26.40The company is up 51% from its price of €17.50 on 01 December 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €30.90 per share.공시 • Feb 19SelectQuote, Inc. Appoints Heidy Robertson-Cooper as Vice President, Healthcare StrategySelectQuote, Inc. has hired Heidy Robertson-Cooper as Vice President, HealthCare Strategy. Robertson-Cooper is a skilled and experienced healthcare leader, spending her career focusing on healthcare policy, value-based payment and delivery system redesign. Most recently, Robertson-Cooper was with the American Academy of Family Physicians as the Division Director, Practice Advancement, where she led strategic planning, execution and operations for four business units. She has also worked with the Missouri Primary Care Association, MissouriHealth+, the Northeast Missouri Health Council and the Sargent Shriver National Center on Poverty Law.Reported Earnings • Feb 10Second quarter 2021 earnings released: EPS US$0.56 (vs US$0.56 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$358.3m (up 103% from 2Q 2020). Net income: US$90.4m (up US$140.7m from 2Q 2020). Profit margin: 25% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue.Analyst Estimate Surprise Post Earnings • Feb 10Revenue beats expectationsRevenue exceeded analyst estimates by 13%. Over the next year, revenue is forecast to grow 42%, compared to a 15% growth forecast for the Insurance industry in Germany.Is New 90 Day High Low • Feb 10New 90-day high: €22.00The company is up 22% from its price of €18.00 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €30.24 per share.공시 • Jan 24SelectQuote, Inc. Hires Scott Dikeman to Health Care BusinessSelectQuote, Inc. announced the hiring of Scott Dikeman. Dikeman recently joined SelectQuote as the Vice President, Strategic Accounts, where he will work on emerging B2B opportunities in health care. He comes to SelectQuote from Cerner.Is New 90 Day High Low • Jan 20New 90-day high: €20.60The company is up 32% from its price of €15.60 on 22 October 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €28.87 per share.이익 및 매출 성장 예측DB:6SJA - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수6/30/20271,743-21N/A6646/30/20261,650-5N/A3043/31/20261,64221-17-2N/A12/31/20251,61920-212N/A9/30/20251,56322-29-17N/A6/30/20251,52725-23-12N/A3/31/20251,489-23546N/A12/31/20241,457-14919N/A9/30/20241,381-481022N/A6/30/20241,322-34415N/A3/31/20241,236-51-23-11N/A12/31/20231,159-50-47N/A9/30/20231,073-47-54N/A6/30/20231,003-59-29-19N/A3/31/2023920-115-76-67N/A12/31/2022895-132-124-108N/A9/30/2022770-292-325-298N/A6/30/2022764-298-373-338N/A3/31/2022809-193-382-339N/A12/31/2021800-151-355-318N/A9/30/202196377-223-193N/A6/30/2021930125-138-115N/A3/31/2021887143-98-81N/A12/31/2020770129-131-114N/A9/30/2020589-12-75-59N/A6/30/2020529-18-77-62N/A3/31/2020464-25-58-46N/A12/31/2019403-26N/A-38N/A9/30/201931540N/A-5N/A6/30/201933760N/A0N/A6/30/201823422N/A-5N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 6SJA 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -183.4%).수익 vs 시장: 6SJA 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -183.4%).고성장 수익: 6SJA 의 수익은 향후 3년간 감소할 것으로 예상됩니다.수익 대 시장: 6SJA 의 수익(연간 5%)이 German 시장(연간 7.1%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 6SJA 의 수익(연간 5%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 6SJA의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YInsurance 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/15 08:00종가2026/05/15 00:00수익2026/03/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스SelectQuote, Inc.는 12명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Steven ValiquetteBarclaysSteven ValiquetteBarclaysDaniel GrosslightCitigroup Inc9명의 분석가 더 보기
공시 • May 07SelectQuote, Inc. Reaffirms Earnings Guidance for the Fiscal Year 2026SelectQuote, Inc. reaffirmed earnings guidance for the Fiscal Year 2026. For the year, the company's revenue is expected to be in a range of $1.61 billion to $1.71 billion.
공시 • Feb 05SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2026SelectQuote, Inc. provided earnings guidance for the fiscal year 2026. For the year, the company revenue expected in a range of $1.61 billion to $1.71 billion.
공시 • Aug 21+ 1 more updateSelectQuote, Inc. Provides Earnings Guidance for the Full Year 2026SelectQuote, Inc. provided earnings guidance for the full year 2026. for the year, the company's revenue expected in a range of $1.650 billion to $1.750 billion.
공시 • May 12SelectQuote, Inc. Provides Earnings Guidance for the Year Ending June 30, 2025SelectQuote, Inc. provided earnings guidance for the year ending June 30, 2025. For the year, the company expects revenue to be in the range of $1.500 billion to $1.575 billion and net income to be in the range of negative $1,000,000 to positive $28,000,000.
공시 • Feb 11SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2025SelectQuote, Inc. provided earnings guidance for the fiscal year ending June 30, 2025. For the period, the company's Revenue is expected in a range of $1.500 billion to $1.575 billion. Net loss expected in a range of $24 million to Net income of $11 million.
공시 • Nov 05SelectQuote, Inc. Provides Unaudited Earnings Guidance for the Fiscal Year Ending June 30, 2025SelectQuote, Inc. provided unaudited earnings guidance for the fiscal year ending June 30, 2025. For the year, the company expects revenue to be in a range of $1.425 billion to $1.525 billion. Net income to be in a range of negative 59 million to $3 million.
공시 • May 07SelectQuote, Inc. Reaffirms Earnings Guidance for the Fiscal Year 2026SelectQuote, Inc. reaffirmed earnings guidance for the Fiscal Year 2026. For the year, the company's revenue is expected to be in a range of $1.61 billion to $1.71 billion.
공시 • Apr 21SelectQuote, Inc. to Report Q3, 2026 Results on May 05, 2026SelectQuote, Inc. announced that they will report Q3, 2026 results Pre-Market on May 05, 2026
공시 • Mar 26SelectQuote, Inc. Receives Notice of Non-Compliance with NYSE Listing StandardOn March 19, 2026, SelectQuote, Inc. (the Company) received a notice (the Notice) from the New York Stock Exchange (the NYSE) indicating that the Company is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period. The Company will notify the NYSE of its intent to cure the stock price deficiency and return to compliance with the continued listing standard. The Company can regain compliance at any time within the six-month cure period following receipt of the Notice if, on the last trading day of any calendar month during the cure period, the Company's common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. The Company intends to closely monitor its stock price during the cure period and will, if necessary, consider available alternatives to cure the stock price deficiency. If the Company determines that curing the deficiency will require taking action that must be approved by the Company's stockholders, the price condition will be deemed cured if the price of the Company's common stock promptly exceeds $1.00 per share following such action and remains above that level for at least the following 30 trading days. The Company's common stock will continue to be listed and traded on the NYSE during the cure period, subject to the Company's compliance with other NYSE continued listing standards.
공시 • Mar 17SelectQuote, Inc. Announces SelectQuote Local Franchise ModelSelectQuote, Inc. announced an initiative to expand its reach and complement its existing, telephonic insurance distribution model. SelectQuote Local will leverage the Company’s marketing, technology, customer service, and carrier relationships to offer consumers its senior health and life insurance products through a franchise model offering local sales and support. SelectQuote Local provides consumers the opportunity to meet with local representatives while still offering the Company’s same affordable and simple way to quickly and easily find the type of insurance to meet their unique needs. Franchise owners will have an opportunity to purchase rights to operate their SelectQuote Local franchise in a particular geographic region, providing a business opportunity for them and a new growth opportunity for the Company.
공시 • Feb 05SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2026SelectQuote, Inc. provided earnings guidance for the fiscal year 2026. For the year, the company revenue expected in a range of $1.61 billion to $1.71 billion.
공시 • Jan 22SelectQuote, Inc. to Report Q2, 2026 Results on Feb 05, 2026SelectQuote, Inc. announced that they will report Q2, 2026 results Pre-Market on Feb 05, 2026
공시 • Oct 23SelectQuote, Inc. to Report Q1, 2026 Results on Nov 06, 2025SelectQuote, Inc. announced that they will report Q1, 2026 results Pre-Market on Nov 06, 2025
공시 • Oct 03SelectQuote, Inc., Annual General Meeting, Nov 11, 2025SelectQuote, Inc., Annual General Meeting, Nov 11, 2025.
공시 • Aug 21+ 1 more updateSelectQuote, Inc. Provides Earnings Guidance for the Full Year 2026SelectQuote, Inc. provided earnings guidance for the full year 2026. for the year, the company's revenue expected in a range of $1.650 billion to $1.750 billion.
공시 • Aug 07SelectQuote, Inc. to Report Q4, 2025 Results on Aug 21, 2025SelectQuote, Inc. announced that they will report Q4, 2025 results Pre-Market on Aug 21, 2025
공시 • Jul 17SelectQuote, Inc. Unveils New Program Designed to Elevate Health Plan Performance by Improving Medication Adherence for Polychronic Medicare BeneficiariesSelectQuote, Inc. announced the expanded launch of their innovative concierge-like service designed to specifically improve medication adherence for Medicare beneficiaries managing multiple chronic conditions and complex medication regimens. SelectQuote's SelectRx pharmacy recently trialed a new approach with a regional health plan that demonstrated over 90% adherence, strengthening HEDIS Star ratings across the triple-weighted cholesterol, diabetes and hypertension measures. The Company plans to expand to additional payers this calendar year and will roll out across SelectRx's pharmacy platform in 2026. This program further demonstrates SelectQuote's deep commitment to driving better health outcomes and greater value for both patients and payer partners. This high-touch solution is purpose-built to address the critical challenge of medication non-adherence, which often leads to preventable hospitalizations, adverse drug interactions, and escalating healthcare costs for the Medicare system. SelectQuote aims to help patients overcome adherence barriers through escalations to its clinical pharmacist team, who can provide specialized intervention. The Company also plans to launch a complementary program for lower risk members to support their continued medication adherence.
공시 • Jul 03SelectQuote, Inc. Announces Demise of Tom Grant, Vice Chairman of the Board of Directors, on July 1, 2025SelectQuote, Inc. announced that William Thomas (Tom) Grant II, Vice Chairman and former President of company, passed away on July 1, 2025, following a battle with cancer. Tom was instrumental in formulating and executing company's strategy over the past fifteen years as the business evolved from a term life insurance brokerage into a diversified insurance and rapidly-growing healthcare services business. His strategic insights and dedication were pivotal to the company’s success. Tom also personally touched the lives of thousands of company associates and their families with his wit, warmth, and ever-present smile.
공시 • May 12SelectQuote, Inc. Provides Earnings Guidance for the Year Ending June 30, 2025SelectQuote, Inc. provided earnings guidance for the year ending June 30, 2025. For the year, the company expects revenue to be in the range of $1.500 billion to $1.575 billion and net income to be in the range of negative $1,000,000 to positive $28,000,000.
공시 • May 05SelectQuote, Inc. to Report Q3, 2025 Results on May 12, 2025SelectQuote, Inc. announced that they will report Q3, 2025 results on May 12, 2025
공시 • Mar 01SelectQuote, Inc. announced that it has received $350 million in funding from Bain Capital, LP, Morgan Stanley, Investment Arm, Newlight Partners LPOn February 28, 2025. SelectQuote, Inc. has closed the transaction. it has issued 350,000 shares of Senior Non-Convertible Preferred Stock at a price of $1,000 per share for proceeds of $350,000,000 and 30,833,333 warrants to purchase shares of the Company’s common stock.
공시 • Feb 12SelectQuote, Inc. announced that it expects to receive $350 million in funding from Bain Capital, LP, Morgan Stanley, Investment Arm, Newlight Partners LPSelectQuote, Inc. announced that it has entered into agreement with Bain Capital, Morgan Stanley Private Credit, and Newlight Partners for gross proceeds of $350 million on February 10, 2025. Additionally, SelectQuote is appointing Chris Wolfe of Bain Capital and Srdjan Vukovic of Newlight Partners to the Board of Directors, each bringing over 20 years of investing and healthcare sector experience to the Company. SelectQuote anticipates Mr. Wolfe and Mr. Vukovic will join the Board upon the closing of the transaction, expected to be on February 28, 2025.
공시 • Feb 11SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2025SelectQuote, Inc. provided earnings guidance for the fiscal year ending June 30, 2025. For the period, the company's Revenue is expected in a range of $1.500 billion to $1.575 billion. Net loss expected in a range of $24 million to Net income of $11 million.
공시 • Feb 04SelectQuote, Inc. to Report Q2, 2025 Results on Feb 10, 2025SelectQuote, Inc. announced that they will report Q2, 2025 results After-Market on Feb 10, 2025
공시 • Nov 05SelectQuote, Inc. Provides Unaudited Earnings Guidance for the Fiscal Year Ending June 30, 2025SelectQuote, Inc. provided unaudited earnings guidance for the fiscal year ending June 30, 2025. For the year, the company expects revenue to be in a range of $1.425 billion to $1.525 billion. Net income to be in a range of negative 59 million to $3 million.
Reported Earnings • Nov 05First quarter 2025 earnings released: US$0.26 loss per share (vs US$0.18 loss in 1Q 2024)First quarter 2025 results: US$0.26 loss per share (further deteriorated from US$0.18 loss in 1Q 2024). Revenue: US$292.3m (up 26% from 1Q 2024). Net loss: US$44.5m (loss widened 44% from 1Q 2024). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.9% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.
New Risk • Oct 29New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$34m Forecast net loss in 2 years: US$1.4m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$1.4m net loss in 2 years). Shareholders have been diluted in the past year (2.2% increase in shares outstanding).
공시 • Oct 23SelectQuote, Inc. to Report Q1, 2025 Results on Nov 04, 2024SelectQuote, Inc. announced that they will report Q1, 2025 results Pre-Market on Nov 04, 2024
공시 • Oct 03SelectQuote, Inc., Annual General Meeting, Nov 12, 2024SelectQuote, Inc., Annual General Meeting, Nov 12, 2024.
New Risk • Sep 15New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Shareholders have been diluted in the past year (2.2% increase in shares outstanding).
Reported Earnings • Sep 14Full year 2024 earnings released: US$0.20 loss per share (vs US$0.35 loss in FY 2023)Full year 2024 results: US$0.20 loss per share (improved from US$0.35 loss in FY 2023). Revenue: US$1.32b (up 32% from FY 2023). Net loss: US$34.1m (loss narrowed 42% from FY 2023). Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 43% per year, which means it is performing significantly worse than earnings.
공시 • Sep 13SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2025SelectQuote, Inc. provided earnings guidance for the fiscal year 2025. For the year, the company expects Revenue in a range of $1.4 billion to $1.5 billion. Net loss expected in a range of $42 million to $6 million.
공시 • Sep 11SelectQuote, Inc. to Report Q4, 2024 Results on Sep 13, 2024SelectQuote, Inc. announced that they will report Q4, 2024 results Pre-Market on Sep 13, 2024
공시 • May 10SelectQuote, Inc. Raises Earnings Guidance for the Fiscal Year 2024SelectQuote, Inc. raised earnings guidance for the fiscal year 2024. For the year, the company's revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion. Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million.
Reported Earnings • May 09Third quarter 2024 earnings released: EPS: US$0.051 (vs US$0.056 in 3Q 2023)Third quarter 2024 results: EPS: US$0.051 (down from US$0.056 in 3Q 2023). Revenue: US$376.4m (up 26% from 3Q 2023). Net income: US$8.55m (down 7.7% from 3Q 2023). Profit margin: 2.3% (down from 3.1% in 3Q 2023). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.
공시 • May 03SelectQuote, Inc. to Report Q3, 2024 Results on May 09, 2024SelectQuote, Inc. announced that they will report Q3, 2024 results Pre-Market on May 09, 2024
New Risk • Feb 29New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$50m Forecast net loss in 2 years: US$1.8m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$3.6m free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$1.8m net loss in 2 years). Share price has been volatile over the past 3 months (9.2% average weekly change).
Reported Earnings • Feb 08Second quarter 2024 earnings released: EPS: US$0.12 (vs US$0.14 in 2Q 2023)Second quarter 2024 results: EPS: US$0.12 (down from US$0.14 in 2Q 2023). Revenue: US$405.4m (up 27% from 2Q 2023). Net income: US$19.4m (down 14% from 2Q 2023). Profit margin: 4.8% (down from 7.1% in 2Q 2023). Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Insurance industry in Germany.
공시 • Feb 08SelectQuote, Inc. Revises Earnings Guidance for the Fiscal Year 2024SelectQuote, Inc. revised earnings guidance for the Fiscal Year 2024. For the year, company expects Revenue in a range of $1.23 billion to $1.3 billion vs prior range of $1.05 billion to $1.2 billion and Net loss expected in a range of $45 million to $22 million vs prior range of $50 million to $22 million.
공시 • Jan 24SelectQuote, Inc. to Report Q2, 2024 Results on Feb 07, 2024SelectQuote, Inc. announced that they will report Q2, 2024 results Pre-Market on Feb 07, 2024
공시 • Nov 03SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2024SelectQuote, Inc. provided earnings guidance for the fiscal year 2024. For the year, the company expects revenue of $232.7 million and net loss of $31.1 million.
Reported Earnings • Nov 03First quarter 2024 earnings released: US$0.18 loss per share (vs US$0.26 loss in 1Q 2023)First quarter 2024 results: US$0.18 loss per share (improved from US$0.26 loss in 1Q 2023). Revenue: US$232.7m (up 43% from 1Q 2023). Net loss: US$31.1m (loss narrowed 27% from 1Q 2023). Revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 6 percentage points per year, which is a significant difference in performance.
공시 • Oct 26SelectQuote, Inc. to Report Q1, 2024 Results on Nov 02, 2023SelectQuote, Inc. announced that they will report Q1, 2024 results After-Market on Nov 02, 2023
공시 • Oct 05SelectQuote, Inc., Annual General Meeting, Nov 14, 2023SelectQuote, Inc., Annual General Meeting, Nov 14, 2023, at 09:00 Central Standard Time. Agenda: To consider the election of two Class I directors named in proxy statement to serve until the 2026 annual meeting of stockholders or until their successors are duly elected and qualified; to consider a proposal to ratify the appointment of Deloitte & Touche LLP as company's independent registered public accounting firm for company's fiscal year ending June 30, 2024; to consider a proposal to approve, by non-binding advisory vote, the compensation of company's named executive officers; and to consider any other business as may properly come before the Annual Meeting.
New Risk • Sep 24New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$59m Forecast net loss in 2 years: US$21m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (US$21m net loss in 2 years).
Recent Insider Transactions • Sep 19President of SelectQuote Senior recently bought €106k worth of stockOn the 18th of September, Joshua Matthews bought around 98k shares on-market at roughly €1.09 per share. This transaction amounted to 32% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €1.2m more in shares than they have sold in the last 12 months.
공시 • Sep 14+ 1 more updateSelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2024SelectQuote, Inc. provided earnings guidance for the fiscal year 2024. For the period, Revenue expected in a range of $1.05 billion to $1.2 billion and Net loss expected in a range of $50 million to $22 million.
New Risk • Sep 14New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$59m Forecast net loss in 2 years: US$1.4m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (US$1.4m net loss in 2 years).
Reported Earnings • Sep 14Full year 2023 earnings released: US$0.35 loss per share (vs US$1.81 loss in FY 2022)Full year 2023 results: US$0.35 loss per share (improved from US$1.81 loss in FY 2022). Revenue: US$1.00b (up 31% from FY 2022). Net loss: US$58.5m (loss narrowed 80% from FY 2022). Revenue is forecast to grow 8.8% p.a. on average during the next 2 years, compared to a 2.6% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 9 percentage points per year, which is a significant difference in performance.
공시 • Aug 24SelectQuote, Inc. to Report Q4, 2023 Results on Sep 13, 2023SelectQuote, Inc. announced that they will report Q4, 2023 results Pre-Market on Sep 13, 2023
Recent Insider Transactions • May 18Vice Chairman recently bought €501k worth of stockOn the 16th of May, William Grant bought around 425k shares on-market at roughly €1.18 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was William's only on-market trade for the last 12 months.
공시 • May 13SelectQuote, Inc. Updates Consolidated Earnings Guidance for the Fiscal Year 2023SelectQuote, Inc. updated consolidated earnings guidance for the fiscal year 2023. For the period, the company expected revenue in a range of $950 million to $970 million. Net loss now expected in a range of $73 million to $55 million.
공시 • May 12SelectQuote, Inc. Provides Consolidated Earnings Guidance for the Third Quarter and Full Year of Fiscal 2023SelectQuote, Inc. provided consolidated earnings guidance for the third quarter and full year of fiscal 2023. For the quarter, the company expects revenue of $299.4 million. Net income of $9.3 million.For the full year, the company expects revenue now expected in a range of $950 million to $970 million. Net loss now expected in a range of $68 million to $48 million.
Reported Earnings • May 11Third quarter 2023 earnings released: EPS: US$0.056 (vs US$0.039 loss in 3Q 2022)Third quarter 2023 results: EPS: US$0.056 (up from US$0.039 loss in 3Q 2022). Revenue: US$299.4m (up 8.8% from 3Q 2022). Net income: US$9.26m (up US$15.7m from 3Q 2022). Profit margin: 3.1% (up from net loss in 3Q 2022). Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Insurance industry in Germany.
공시 • Feb 08SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2023SelectQuote, Inc. provides earnings guidance for the fiscal year 2023. The company now expects revenue in a range of $910 million to $960 million. Net loss now expected in a range of $94 million to $78 million.
Reported Earnings • Feb 08Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.84 loss in 2Q 2022)Second quarter 2023 results: EPS: US$0.14 (up from US$0.84 loss in 2Q 2022). Revenue: US$319.2m (up 64% from 2Q 2022). Net income: US$22.5m (up US$159.5m from 2Q 2022). Profit margin: 7.1% (up from net loss in 2Q 2022). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Insurance industry in Germany.
공시 • Jan 20SelectQuote, Inc. to Report Q2, 2023 Results on Feb 07, 2023SelectQuote, Inc. announced that they will report Q2, 2023 results Pre-Market on Feb 07, 2023
공시 • Jan 06+ 1 more updateSelectQuote, Inc. Provides Earnings Guidance for the Second Quarter 2023SelectQuote, Inc. provides earnings guidance for the second quarter 2023. Revenue for the second quarter of fiscal year 2023 expected in a range of $300 million to $320 million. Net income for the second quarter of fiscal year 2023 expected in a range of $11 million to $23 million.
Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 3 highly experienced directors. Vice Chairman Tom Grant is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Nov 04First quarter 2023 earnings released: US$0.26 loss per share (vs US$0.29 loss in 1Q 2022)First quarter 2023 results: US$0.26 loss per share (improved from US$0.29 loss in 1Q 2022). Revenue: US$162.5m (up 3.1% from 1Q 2022). Net loss: US$42.5m (loss narrowed 9.9% from 1Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Insurance industry in Germany.
공시 • Nov 04Selectquote, Inc. Reaffirms Earnings Guidance for the Fiscal Year 2023SelectQuote, Inc. reaffirmed earnings guidance for the Fiscal Year 2023. For the year, the company's Revenue expected in a range of $850 million to $950 million and net loss expected in a range of $113 million to $89 million.
공시 • Oct 27SelectQuote Announces Receipt of Continued Listing Standard Notice from NYSESelectQuote, Inc. (the “Company”) announced that it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) indicating that the Company is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period. The Company will notify the NYSE of its intent to cure the stock price deficiency and return to compliance with the continued listing standard. The Company can regain compliance at any time within the six-month cure period following receipt of the Notice if, on the last trading day of any calendar month during the cure period, the Company’s common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. The Company intends to closely monitor its stock price during the cure period and will, if necessary, consider available alternatives to cure the stock price non-compliance.
공시 • Oct 15SelectQuote, Inc. to Report Q1, 2023 Results on Nov 03, 2022SelectQuote, Inc. announced that they will report Q1, 2023 results Pre-Market on Nov 03, 2022
공시 • Oct 07SelectQuote, Inc., Annual General Meeting, Nov 15, 2022SelectQuote, Inc., Annual General Meeting, Nov 15, 2022, at 09:00 Central Standard Time. Agenda: To consider the election of three Class III directors named in this proxy statement to serve until the 2025 annual meeting of stockholders or until their successors are duly elected and qualified; to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending June 30, 2023; to approve, by non-binding advisory vote, the Company’s executive compensation program; and to transact other business.
Reported Earnings • Aug 30Full year 2022 earnings released: US$1.81 loss per share (vs US$0.81 profit in FY 2021)Full year 2022 results: US$1.81 loss per share (down from US$0.81 profit in FY 2021). Revenue: US$764.0m (down 19% from FY 2021). Net loss: US$297.5m (down 327% from profit in FY 2021). Over the next year, revenue is forecast to grow 19%, compared to a 27% growth forecast for the Insurance industry in Germany.
공시 • Aug 30Selectquote, Inc. Reports Unaudited Consolidated Impairment for the Three Months Ended June 30, 2022SelectQuote, Inc. reported unaudited consolidated impairment for the three months ended June 30, 2022. For the quarter, the company reported Goodwill impairment of $44,596,000. Impairment of long-lived assets is $3,147,000.
공시 • Aug 26SelectQuote, Inc. Appoints Alan Muney as Chief Medical OfficerSelectQuote, Inc. has hired Alan Muney, MD, as part-time Chief Medical Officer. Dr. Muney will focus on healthcare strategy solutions for SelectQuote healthcare services, which encompasses Population Health and SelectRx, bringing extensive experience operating clinical strategy within a national Medicare Advantage health plan and large provider groups. Dr. Muney will provide strategic guidance on program development and execution for health plan initiatives focusing on member engagement, clinical quality, and care delivery. He will also drive initiatives that support healthcare services members in accessing high-value medical and clinical services to achieve improved health outcomes. Dr. Muney is a physician and executive leader with more than 35 years of experience leading healthcare payor and provider organizations. Most recently, he served as Cigna's Chief Medical Officer and EVP of Total Health and Network, overseeing clinical strategy, coverage policy, quality measurement and improvement, and total health physician and clinical operations. Before Cigna, Dr. Muney was an Executive Director in the Private Equity Group at Blackstone and the CEO of Equity Healthcare, which he founded to manage the healthcare costs of Blackstone's portfolio companies. Alan was also EVP, Chief Medical Officer of Oxford Health Plans, and Chief Medical Officer of UnitedHealthcare of the Northeast region from 1998-2007.
공시 • Jul 28SelectQuote, Inc. to Report Q4, 2022 Results on Aug 18, 2022SelectQuote, Inc. announced that they will report Q4, 2022 results Pre-Market on Aug 18, 2022
공시 • Jun 26SelectQuote, Inc.(NYSE:SLQT) dropped from Russell 2000 Growth IndexSelectQuote, Inc.(NYSE:SLQT) dropped from Russell 2000 Growth Index
공시 • May 20Selectquote, Inc. Announces CFO ChangesSelectQuote, Inc. announced the departure of Chief Financial Officer Raff Sadun after 5 years at SelectQuote to pursue a new opportunity outside of the industry. The Board of Directors approved the appointment of Ryan Clement, SVP of Financial Planning & Analysis, as interim CFO effective upon Sadun’s departure at the end of the month. Prior to joining SelectQuote, Clement served as the CFO of a software technology company and has over a decade of experience in senior-level finance and operations roles. Clement will continue to lead SelectQuote’s Financial Planning & Analysis organization while acting as interim CFO. The company’s financial reporting and accounting functions will be led by Stephanie Fisher, SelectQuote’s Chief Accounting Officer, who will assume the role of principal accounting officer effective upon Sadun’s departure. The company has initiated a national search for a permanent Chief Financial Officer.
Reported Earnings • May 09Third quarter 2022 earnings released: US$0.039 loss per share (vs US$0.22 profit in 3Q 2021)Third quarter 2022 results: US$0.039 loss per share (down from US$0.22 profit in 3Q 2021). Revenue: US$275.1m (up 3.7% from 3Q 2021). Net loss: US$6.45m (down 118% from profit in 3Q 2021). Over the next year, revenue is forecast to grow 9.7%, compared to a 19% growth forecast for the industry in Germany.
Board Change • May 09High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 3 highly experienced directors. Vice Chairman Tom Grant is the most experienced director on the board, commencing their role in 2010. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • May 06Selectquote, Inc. Provides Earnings Guidance for the Year Ending June 30, 2022SelectQuote, Inc. provided earnings guidance for the year ending June 30, 2022. For the period, the company's Revenue expected in a range of $810 million to $850 million. Net Loss expected in a range of $255 million to $236 million.
공시 • Apr 26SelectQuote, Inc. to Report Q3, 2022 Results on May 05, 2022SelectQuote, Inc. announced that they will report Q3, 2022 results Pre-Market on May 05, 2022
공시 • Mar 03Selectquote, Inc. Introduces Healthcare Advisory BoardSelectQuote, Inc. announced the formation of a Healthcare Advisory Board to help the company strengthen the mission and clinical strategy of Population Health. This group of world-class experts will advise Population Health on ways to empower, engage and educate consumers on healthcare solutions and benefits, equipping them to lead healthier lives through improved health outcomes while reducing costs for patients and the healthcare system. This group of world-renowned leaders brings comprehensive healthcare expertise from the pharmaceutical, health IT, payer, provider, and regulatory market segments and will provide important insight and expertise to help shape continuing innovation and growth at Population Health. The Advisory Board will be led by SelectQuote Board members Kavita Patel, MD and Earl “Trace” Devanny. Advisory Board members include: Basit Chaudhry, MD is an internal medicine physician and medical technologist who founded Tuple Health in 2013. His expertise spans healthcare payment, clinical service redesign, and the use of data analytics to improve clinical and financial performance in healthcare. Alan Muney, MD is currently an external advisor to Bain & Company, and a Senior Advisor for Pritzker Private Capital, NEA and Arsenal Capital Partners. From 2010 to 2018, he was the Executive Vice President and Chief Medical Officer for Cigna, leading the company’s health management and network contracting activities. Joe Grogan is a former Assistant to the President, Director of the Domestic Policy Council and Associate Director, Health Programs for the Office of Management and Budget. He is currently a Fellow with the USC Schaeffer Center. He has served at senior management roles at Amgen, Inc., and Gilead Sciences, Inc., and he has an extensive background working with the FDA on regulatory, legislative and policy initiatives. Rebekah Gee, MD is the President and Founder of Nest Health and CEO of Healthcare Services for LSU Health. She formerly served as Secretary of the Louisiana Department of Health, the state’s large agency. She is a policy expert and is widely published in health services research, and has served in numerous additional state and national policy roles. Dr. Patel is currently a Fellow with the Brookings Institute and served in the Obama Administration as Director of Policy for the Office of Intergovernmental Affairs and Public Engagement. She is also an advisor to the Bipartisan Policy Center and a member of Health and Human Services Physician Focused Payment Model Technical Advisory Committee. Devanny is the former CEO of Tract Manager, a provider of healthcare strategic sourcing and compliance application suites. From 2014 to 2016, he served as President of Nuance Communications’ healthcare business. He has also led healthcare company Trizetto Corporation and health information technology company Cerner Corporation.
공시 • Feb 10SelectQuote, Inc. announced delayed 10-Q filingOn 02/09/2022, SelectQuote, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Buying Opportunity • Feb 09Now 43% undervalued after recent price dropOver the last 90 days, the stock is down 67%. The fair value is estimated to be US$5.65, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.9% over the last year. The company became loss making over the last year.
Reported Earnings • Feb 08Second quarter 2022 earnings: EPS in line with expectations, revenues disappointSecond quarter 2022 results: US$0.84 loss per share (down from US$0.56 profit in 2Q 2021). Revenue: US$195.0m (down 46% from 2Q 2021). Net loss: US$137.0m (down 252% from profit in 2Q 2021). Revenue missed analyst estimates by 57%. Over the next year, revenue is forecast to grow 83%, compared to a 15% growth forecast for the industry in Germany.
공시 • Feb 08SelectQuote, Inc. Provides Earnings Guidance for the Full Year of Fiscal 2022SelectQuote, Inc. provided earnings guidance for the full year of fiscal 2022. For the full year, the company expects revenue in a range of $810 million to $850 million and net Loss in a range of $255 million to $236 million.
Reported Earnings • Nov 05First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.005 profit in 1Q 2021)The company reported a soft first quarter result with weaker earnings and weaker control over costs, although revenues improved. First quarter 2022 results: Revenue: US$159.9m (up 29% from 1Q 2021). Net loss: US$45.4m (down US$46.2m from profit in 1Q 2021).
Recent Insider Transactions • Sep 12Vice Chairman recently bought €1.5m worth of stockOn the 10th of September, William Grant bought around 145k shares on-market at roughly €10.50 per share. In the last 3 months, they made an even bigger purchase worth €1.7m. This was William's only on-market trade for the last 12 months.
Valuation Update With 7 Day Price Move • Sep 03Investor sentiment improved over the past weekAfter last week's 38% share price gain to €9.37, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 10x in the Insurance industry in Germany. Total loss to shareholders of 44% over the past year.
Recent Insider Transactions • Sep 01Chief Operating Officer recently bought €1.7m worth of stockOn the 30th of August, William Grant bought around 230k shares on-market at roughly €7.50 per share. This was the largest purchase by an insider in the last 3 months. This was William's only on-market trade for the last 12 months.
공시 • Aug 28SelectQuote, Inc. Provides Earnings Guidance for the Fiscal Year 2022SelectQuote, Inc. provided earnings guidance for the fiscal year 2022. For the period, The company expects revenue to be in the range of $1.25 billion and $1.4 billion, which would represent revenue growth of 33% and 49% year-over-year.
Reported Earnings • Aug 26Full year 2021 earnings released: EPS US$0.81 (vs US$0.16 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: US$937.8m (up 76% from FY 2020). Net income: US$131.0m (up US$147.1m from FY 2020). Profit margin: 14% (up from net loss in FY 2020). The move to profitability was driven by higher revenue.
공시 • Aug 19Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against SelectQuote, IncGlancy Prongay & Murray LLP (‘GPM’) announced that it has filed a class action lawsuit in the United States District Court for the Southern District of New York captioned Hartel v.SelectQuote, Inc., et al., (Case No. 21-cv-06903) on behalf of persons and entities that purchased or otherwise acquired SelectQuote, Inc. (‘SelectQuote’ or ‘the Company’) securities between February 8, 2021 and May 11, 2021, inclusive (the ‘Class Period’). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ‘Exchange Act’). Investors are hereby notified that they have 60 days from this notice to move the Court to serve as lead plaintiff in this action. On May 11, 2021, SelectQuote held a conference call in connection with its third quarter 2021 financial results during which it disclosed that its fourth quarter results would be impacted by a ‘negative cohort and tail adjustment’ due to ‘lower second-term persistency for the 2019 cohort.’ On this news, the Company’s share price fell $5.50, or 20%, to close at $21.90 per share on May 12, 2021, on unusually heavy trading volume. The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made material misrepresentations concerning the following: (1) that SelectQuote’s 2019 cohort was underperforming; (2) that, as a result, the Company’s financial results would be adversely impacted; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Valuation Update With 7 Day Price Move • Aug 14Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to US$11.74, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Insurance industry in Germany. Total loss to shareholders of 32% over the past year.
공시 • Jun 28+ 2 more updatesSelectQuote, Inc.(NYSE:SLQT) dropped from Russell 3000 Value IndexSelectQuote, Inc.(NYSE:SLQT) dropped from Russell 3000 Value Index
Reported Earnings • May 13Third quarter 2021 earnings released: EPS US$0.22 (vs US$0.23 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: US$266.9m (up 80% from 3Q 2020). Net income: US$36.5m (up 76% from 3Q 2020). Profit margin: 14% (in line with 3Q 2020).
공시 • May 12SelectQuote, Inc. Provides Consolidated Earnings Guidance for the Full Year Ending June 30, 2021SelectQuote, Inc. provided consolidated earnings guidance for the full year ending June 30, 2021. For the year, the company expects revenue to be in the range of $920 million to $940 million and net income to be in the range of $130 million to $138 million.
공시 • May 04SelectQuote, Inc. (NYSE:SLQT) acquired Express Med Pharmaceuticals, Inc.SelectQuote, Inc. (NYSE:SLQT) acquired Express Med Pharmaceuticals, Inc. on May 3, 2021. MyMedPak will be branded as SelectRx. SelectQuote, Inc. (NYSE:SLQT) completed the acquisition of Express Med Pharmaceuticals, Inc. on May 3, 2021.
Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to US$22.20, the stock is trading at a trailing P/E ratio of 27.3x, down from the previous P/E ratio of 32.5x. This compares to an average P/E of 13x in the Insurance industry in Germany.
공시 • Mar 05SelectQuote, Inc. has completed a Follow-on Equity Offering in the amount of $291.5 million.SelectQuote, Inc. has completed a Follow-on Equity Offering in the amount of $291.5 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 10,600,000 Price\Range: $27.5
Is New 90 Day High Low • Mar 01New 90-day high: €26.40The company is up 51% from its price of €17.50 on 01 December 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €30.90 per share.
공시 • Feb 19SelectQuote, Inc. Appoints Heidy Robertson-Cooper as Vice President, Healthcare StrategySelectQuote, Inc. has hired Heidy Robertson-Cooper as Vice President, HealthCare Strategy. Robertson-Cooper is a skilled and experienced healthcare leader, spending her career focusing on healthcare policy, value-based payment and delivery system redesign. Most recently, Robertson-Cooper was with the American Academy of Family Physicians as the Division Director, Practice Advancement, where she led strategic planning, execution and operations for four business units. She has also worked with the Missouri Primary Care Association, MissouriHealth+, the Northeast Missouri Health Council and the Sargent Shriver National Center on Poverty Law.
Reported Earnings • Feb 10Second quarter 2021 earnings released: EPS US$0.56 (vs US$0.56 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$358.3m (up 103% from 2Q 2020). Net income: US$90.4m (up US$140.7m from 2Q 2020). Profit margin: 25% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue.
Analyst Estimate Surprise Post Earnings • Feb 10Revenue beats expectationsRevenue exceeded analyst estimates by 13%. Over the next year, revenue is forecast to grow 42%, compared to a 15% growth forecast for the Insurance industry in Germany.
Is New 90 Day High Low • Feb 10New 90-day high: €22.00The company is up 22% from its price of €18.00 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €30.24 per share.
공시 • Jan 24SelectQuote, Inc. Hires Scott Dikeman to Health Care BusinessSelectQuote, Inc. announced the hiring of Scott Dikeman. Dikeman recently joined SelectQuote as the Vice President, Strategic Accounts, where he will work on emerging B2B opportunities in health care. He comes to SelectQuote from Cerner.
Is New 90 Day High Low • Jan 20New 90-day high: €20.60The company is up 32% from its price of €15.60 on 22 October 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €28.87 per share.